Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor
- 1 September 1987
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 55 (9) , 2230-2233
- https://doi.org/10.1128/iai.55.9.2230-2233.1987
Abstract
Lewis lung carcinoma and EMT6 sarcoma growing as solid tumors in mice caused a gradual increase in the susceptibility of the animals to lethal toxicity of endotoxins (lipopolysaccharides [LPS]). By day 15 following inoculation of the tumors, the 50% lethal dose of LPS, which in normal mice was approximately 400 micrograms, decreased to 2 micrograms for the sarcoma-bearing mice and 0.1 microgram for the carcinoma-bearing mice. This sensitization to endotoxin was paralleled by a high sensitization to tumor necrosis factor (TNF). Human recombinant TNF given to normal mice was lethal at about 500 micrograms. It was lethal for 50% of the animals bearing EMT6 or Lewis lung carcinoma tumors in amounts of 4 and 0.01 micrograms, respectively, on day 15 following tumor inoculation. The sensitization of tumor-bearing animals to LPS and TNF was paralleled by marked granulocytosis.This publication has 23 references indexed in Scilit:
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987
- Biological Aspects of Tumor Necrosis FactorImmunobiology, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factorEuropean Journal of Biochemistry, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Different structural requirements of endotoxic glycolipid for tumor regression and endotoxic activityBiochemical and Biophysical Research Communications, 1982
- The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.The Journal of Experimental Medicine, 1978
- T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.The Journal of Experimental Medicine, 1977
- A New Method for the Extraction of R LipopolysaccharidesEuropean Journal of Biochemistry, 1969
- EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISMThe Journal of Experimental Medicine, 1964